# Tuberculous mastitis, the great imitator in breast disease: a case report with diagnostic and therapeutic challenges

**Authors:** Serena Vita, Claudia Piccolo, Gaetano Maffongelli, Alberta Villanacci, Nicoletta Fusco, Laura Scorzolini, Claudia Palazzolo, Ada Petrone, Angela Corpolongo, Carla Nisii, Fabrizio Albarello, Beomonte Zobel, Francesca Svegliati, Franca Del Nonno, Daniele Colombo, Fabio Di Cesare, Emanuele Nicastri, Stefania Ianniello

PMC · DOI: 10.1186/s40249-025-01391-9 · 2026-01-13

## TL;DR

A 30-year-old woman with breast symptoms was diagnosed with rare breast tuberculosis, highlighting the difficulty in diagnosing this condition without clear microbiological evidence.

## Contribution

The paper presents a rare case of breast tuberculosis and emphasizes the role of clinical judgment and multidisciplinary evaluation in its diagnosis.

## Key findings

- Breast tuberculosis can mimic other diseases and may require a multidisciplinary approach for diagnosis.
- Empirical antitubercular therapy led to progressive clinical improvement despite negative microbiological tests.
- Resolution of symptoms and pulmonary nodules occurred within 7 months of treatment initiation.

## Abstract

Extrapulmonary tuberculosis (TB) remains a diagnostic challenge due to its nonspecific clinical manifestations, low bacterial burden, and the need for invasive procedures to obtain diagnostic samples. Breast TB, a particularly rare form, can closely mimic other conditions such as inflammatory breast carcinoma.

A 30-year-old Peruvian woman with no relevant medical history was admitted with painful erythema of the right breast and two fistulous tracts secreting purulent discharge. Initial microbiological tests, including interferon-gamma release assay (IGRA) and cultures, were negative. Imaging revealed multiple pulmonary micronodules, and breast biopsy demonstrated granulomatous inflammation with Langhans giant cells. Despite negative PCR and culture results for mycobacteria, empirical antitubercular therapy was initiated based on clinical, radiological, and histopathological evidence. The patient was initiated on standard antitubercular therapy, which was simplified two months later. Progressive clinical improvement was observed, with complete ulcer healing by month 4 and resolution of pulmonary nodules by month 7. By month 12, she remained in good clinical condition with no signs of recurrence.

This case highlights the diagnostic complexity of breast TB and underscores the importance of a multidisciplinary approach in the absence of microbiological confirmation. Clinical context, imaging, and histology may guide successful empirical treatment and improve patient outcomes.

## Linked entities

- **Diseases:** tuberculosis (MONDO:0018076), inflammatory breast carcinoma (MONDO:0006804)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}
- **Diseases:** deaths (MESH:D003643), COVID-19 (MESH:D000086382), chronic (MESH:D002908), Acute and chronic inflammation (MESH:D007249), abscess (MESH:D000038), breast cancer (MESH:D001943), granulomatous (MESH:D013968), Breast TB (MESH:D061325), skin lesions (MESH:D012871), painful (MESH:D010146), TM (MESH:D008413), erythema (MESH:D004890), infection (MESH:D007239), fistulas (MESH:D005402), Extrapulmonary tuberculosis (MESH:D000092225), Langhans giant cell (MESH:D018286), erythema nodosum (MESH:D004893), inflammatory breast carcinoma (MESH:D058922), M. tuberculosis infection (MESH:D014376), malignancies (MESH:D009369), Infectious Diseases (MESH:D003141), fibrosis (MESH:D005355), ulcer (MESH:D014456), tubercular complex (MESH:D014390), breast disease (MESH:D001941), granulomatous mastitis (MESH:D058890), HIV/AIDS (MESH:D015658)
- **Chemicals:** eosin (MESH:D004801), rifampicin (MESH:D012293), gadobutrol (MESH:C090600), daptomycin (MESH:D017576), paraffin (MESH:D010232), hematoxylin (MESH:D006416), ethambutol (MESH:D004977), lipid (MESH:D008055), pyrazinamide (MESH:D011718), piperacillin/tazobactam (MESH:D000077725), isoniazid (MESH:D007538), amoxicillin-clavulanate (MESH:D019980)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycobacterium tuberculosis (species) [taxon 1773], Staphylococcus epidermidis (species) [taxon 1282], Mycobacteriales (order) [taxon 85007]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12797753/full.md

---
Source: https://tomesphere.com/paper/PMC12797753